Erratum: Diagnosis and management of tuberculosis in transplant donors: A donor-derived infections consensus conference report (American Journal of Transplantation (2012) 12 (2288 -2300) DOI: 10.1111/j.1600-6143.2012.04205.x);Diagnosis and management of tuberculosis in transplant donors: A donor-derived infections consensus conference report

American Journal of Transplantation

Volumn 12, Issue 9, 2012, Pages 2288-2300

  Morris, M I ^a   Daly, J S ^b   Blumberg, E ^c   Kumar, D ^d   Sester, M ^e   Schluger, N ^f   Kim, S H ^g   Schwartz, B S ^h   Ison, M G ⁱ   Humar, A ^d   Singh, N ^j   Michaels, M ^k   Orlowski, J P ^l   Delmonico, F ^m   Pruett, T ⁿ   John, G T ^o   Kotton, C N ^p  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e SAARLAND UNIVERSITY   (Germany)

^f NewYork Presbyterian Hospital   (United States)

^g Asan Medical Center   (South Korea)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^k CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^l LifeShare of Oklahoma   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^o ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^p HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

Donor derived; interferon gamma release assay; solid organ transplant; TB screening; tuberculosis

Indexed keywords

ISONIAZID;

CONFERENCE PAPER; DISEASE TRANSMISSION; GRAFT INFECTION; HUMAN; INCIDENCE; INFECTION RISK; LIVING DONOR; ORGAN DONOR; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SCREENING; TUBERCULOSIS;

EID: 84865575706     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12057     Document Type: Erratum

References (43)

1. Singh N, Paterson DL,. Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management. Clin Infect Dis 1998; 27: 1266-1277. (Pubitemid 29242482)
2. Queipo JA, Broseta E, Santos M, Sanchez-Plumed J, Budia A, Jimenez-Cruz F,. Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 2003; 9: 518-525.
3. Munoz P, Rodriguez C, Bouza E,. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40: 581-587. (Pubitemid 40270229)
4. Morales P, Briones A, Torres JJ, Sole A, Perez D, Pastor A,. Pulmonary tuberculosis in lung and heart-lung transplantation: Fifteen years of experience in a single center in Spain. Transplant Proc 2005; 37: 4050-4055. (Pubitemid 43015251)
5. Clemente WT, Faria LC, Lima SS, Vilela EG, Lima AS, Velloso LF, et al,. Tuberculosis in liver transplant recipients: A single Brazilian center experience. Transplantation 2009; 87: 397-401.
6. Subramanian A, Dorman S,. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S57-S62.
7. Aguado JM, Torre-Cisneros J, Fortun J, et al,. Tuberculosis in solid-organ transplant recipients: Consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48: 1276-1284.
8. Transplantation-transmitted tuberculosis-Oklahoma and Texas, 2007. MMWR 2008; 57: 333-336.
9. John GT, Shankar V,. Mycobacterial infections in organ transplant recipients. Semin Respir Infect 2002; 17: 274-283. (Pubitemid 35453644)
10. Ison MG, Nalesnik MA,. An update on donor-derived disease transmission in organ transplantation. Am J Transplant 2011; 11: 1123-1130.
11. Kumar D, Humar A,. Tuberculosis and transplantation: Battling the opportunist. Clin Infect Dis 2009; 48: 1666-1668.
12. Winthrop KL, Kubak BM, Pegues DA, et al,. Transmission of mycobacterium tuberculosis via lung transplantation. Am J Transplant 2004; 4: 1529-1533. (Pubitemid 39159069)
13. Ison MG, Hager J, Blumberg E, et al,. Donor-derived disease transmission events in the United States: Data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009; 9: 1929-1935.
14. Trends in tuberculosis-United States, 2010. MMWR 2011; 60: 333-337.
15. Sester M, Sotgiu G, Lange C, et al,. Interferon-Î release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis. Eur Respir J 2011; 37: 100-111.
16. Pai M, Zwerling A, Menzies D,. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
17. Mack U, Migliori GB, Sester M, et al,. LTBI: Latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956-973.
18. Sester U, Wilkens H, van Bentum K, et al,. Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs. Eur Respir J 2009; 34: 702-710.
19. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A,. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008; 177: 1164-1170. (Pubitemid 351717577)
20. Aichelburg MC, Rieger A, Breitenecker F, et al,. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009; 48: 954-962.
21. Diel R, Goletti D, Ferrara G, et al,. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: Asystematic review and meta-analysis. Eur Respir J 2011; 37: 88-99.
22. Mancuso JD, Mazurek GH, Tribble D, et al,. Discordance among Commercially Available Diagnostics for Latent Tuberculosis Infection. Am J Respir Crit Care Med 2012; 185: 427-434.
23. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K,. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR 2010; 59: 1-25.
24. Cho OH, Park KH, Kim SM, et al,. Diagnostic performance of T-SPOT.TB for extrapulmonary tuberculosis according to the site of infection. J Infect 2011; 63: 362-369.
25. Nunn AJ, Phillips PP, Mitchison DA,. Timing of relapse in short-course chemotherapy trials for tuberculosis. Int J Tuberc Lung Dis 2010; 14: 241-242.
26. OPTN. 4.0: Identification of transmissible diseases in organ recipients. 2010 Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/ pdfs/policy-16.pdf. Accessed July 15, 2011.
27. Agarwal SK, Gupta S, Dash SC, Bhowmik D, Tiwari SC,. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 2004; 36: 425-431.
28. John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK,. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60: 1148-1153. (Pubitemid 34205816)
29. John GT, Thomas PP, Thomas M, Jeyaseelan L, Jacob CK, Shastry JC,. A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 1994; 57: 1683-1684. (Pubitemid 24191653)
30. Treatment of tuberculosis. MMWR 2003; 52: 1-77.
31. Torre-Cisneros J, Caston JJ, Moreno J, et al,. Tuberculosis in the transplant candidate: Importance of early diagnosis and treatment. Transplantation 2004; 77: 1376-1380. (Pubitemid 38668430)
32. Currie AC, Knight SR, Morris PJ,. Tuberculosis in renal transplant recipients: The evidence for prophylaxis. Transplantation 2010; 90: 695-704.
33. Trends in tuberculosis-United States, 2008. MMWR 2009; 58: 249-253.
34. Dorman SE,. Coming-of-age of nucleic acid amplification tests for the diagnosis of tuberculosis. Clin Infect Dis 2009; 49: 55-57.
35. Laraque F, Griggs A, Slopen M, Munsiff SS,. Performance of nucleic acid amplification tests for diagnosis of tuberculosis in a large urban setting. Clin Infect Dis 2009; 49: 46-54.
36. Boddie DE, Currie DG, Eremin O, Heys SD,. Immune suppression and isolated severe head injury: A significant clinical problem. Br J Neurosurg 2003; 17: 405-417. (Pubitemid 37421565)
37. Meert KL, Long M, Kaplan J, Sarnaik AP,. Alterations in immune function following head injury in children. Crit Care Med 1995; 23: 822-828.
38. Bergamini BM, Losi M, Vaienti F, et al,. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 2009; 123: e419-e424.
39. Detjen AK, Keil T, Roll S, et al,. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: 322-328. (Pubitemid 47101028)
40. Torre-Cisneros J, Doblas A, Aguado JM, et al,. Tuberculosis after solid-organ transplant: Incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009; 48: 1657-1665.
41. Organization WH,. Global tuberculosis control 2010. 2010 Available at: http://www.who.int/tb/publications/global-report/2010/en/index.html. Accessed November 1, 2011.
42. Huebner RE, Schein MF, Bass JB, Jr., The tuberculin skin test. Clin Infect Dis 1993; 17: 968-975. (Pubitemid 23358739)
43. Diel R, Loddenkemper R, Nienhaus A,. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: A metaanalysis. Chest 2010; 137: 952-968.